Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Effects of empagliflozin on cardiac remodeling post-MI
Jaclyn Carberry, MD
- ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
C. David Mazer, MD
- ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
Deepak Bhatt, MD
- ESC Congress 2024
Predicting 30-year CV outcomes in women
Paul Ridker, MD